Cipla Limited delivered a strong set of numbers in the second quarter of fiscal 2024 and also outlined pipeline promise, though uncertainty and ongoing speculation around a potential stake sale by the promoter group may be fueling some “distraction” across the ranks. (see side box)
Stake Sale Speculation
Cipla’s senior management gave little away when it came to speculation around the founding Hamied family’s talks for a potential stake sale.(Also see "'Evergreen' Cipla: Chair Hamied Talks New Technologies Amid 'Speculative' Sale News" - Scrip, 11 August, 2023.)
Cipla’s MD and global CEO, Umang Vohra sought to distinguish between the promoters and the company. "We have not heard anything, either way, in terms of the transactions yet. We've been saying that this is speculative from the beginning. We maintain that if there is ever anything that requires a public disclosure, it will be disclosed at that time,” Vohra reiterated at a media briefing.(Also see "Will More Indian Family-Owned Firms Hand Over The Baton To PEs?" - Scrip, 31 July, 2023.)
The executive, though, did indicate that the on-and-off speculation and related uncertainty was leading to some anxiety, though Cipla’s philosophy has always been about investing for the future and “events” should not make a difference to that.
“As a human being, I'm anxious because so many things depend on this decision. Obviously, all of us continuing to work in the organization, that's one big thing,” Vohra said.
“What's more important is just the distraction that this could cause in the business. We're all human beings and get distracted with what happens and that distraction creates difficulties for us in the way we engage with each other and we engage with the organization. That I believe is the biggest impact of this uncertainty”.
Private equity firms and peer Torrent Pharmaceuticals Ltd. have been speculated to be in the fray to acquire a holding in Cipla, though reports in the local media suggest that valuation differences have cropped up stalling, at least for now, Torrent’s most ambitious M&A manoeuvre so far in its long history.(Also see "India M&A Hourglass: Control Deals, ‘FOMO’, Monetization Calls At Family-Owned Firms" - Scrip, 12 September, 2023.)(Also see "Torrent Evasive On Cipla Question, But Comfortable With Domestic Acquisitions" - Scrip, 27 October, 2023.)(Also see "More Interest In Speculated Cipla Stake Sale: Portfolio, Cultural Fit Will Matter" - Scrip, 4 September, 2023.)
![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
